ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: TH-OR88

Left Ventricular Systolic Dysfunction in the NBCe1-B/C Knockout Mouse: A Possible Unappreciated Phenotype of Congenital Proximal Renal Tubular Acidosis (pRTA)

Session Information

Category: Hypertension and CVD

  • 1601 Hypertension and CVD: Basic

Authors

  • Brady, Clayton, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, United States
  • Marshall, Aniko, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, United States
  • Eagler, Lisa A., University at Buffalo, Buffalo, New York, United States
  • Pon, Thomas M., University at Buffalo, Buffalo, New York, United States
  • Weil, Brian R., University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, United States
  • Lang, Jennifer K., University at Buffalo, Buffalo, New York, United States
  • Parker, Mark, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, United States
Background

Congenital proximal renal tubular acidosis (pRTA) is caused by autosomal recessive mutations in the SLC4A4 gene that encodes the electrogenic Na+/2HCO3 cotransporter NBCe1. Congenital pRTA is characterized by severe acidemia due to the loss of the kidney-specific NBCe1-A variant, which consequently impairs proximal tubule HCO3- transport. However, congenital pRTA also presents with growth retardation, intellectual disability, and ocular and dental abnormalities. Intriguingly, a mouse model lacking NBCe1-B and NBCe1-C (variants which have predominantly extra-renal expression) but with intact NBCe1-A, recapitulates the spectrum of ailments of congenital pRTA without the acidemia. No cardiac phenotype has been reported in congenital pRTA patients, however recent evidence from a virally-induced partial knockdown of cardiac NBCe1 in rats suggests that NBCe1-B is cardioprotective. Therefore, we assessed NBCe1-B/C knockout mice (KOb/c) for signs of cardiac impairment.

Methods

Echocardiography, intraventricular pressure-volume (PV), and electrocardiogram measurements were used to assess cardiac function in vivo. Heart-weight to body-weight ratio and cardiomyocyte area were used to assess for signs of cardiac hypertrophy. The Ca2+-sensitive dye Fura-2 AM and an IonOptix imaging system was used to assess Ca2+-transients in isolated cardiomyocytes. Lastly, RNA-seq was used to investigate transcriptional changes in KOb/c hearts.

Results

We observed elevated end-diastolic and end-systolic volumes as well as a reduced left ventricular ejection fraction in KOb/c mice. PV loop analysis revealed reductions in load-independent contractility but not relaxation. Cardiac hypertrophy was not present in KOb/c mice. The QT interval was not different between genotypes, however we observed increased QT variability in KOb/c mice. We further found a reduction in the amplitude of Ca2+-transients in cardiomyocytes isolated from KOb/c mice, providing an explanation for the reduction in contractility. Lastly, RNA-seq analysis revealed upregulation of gene-sets associated with membrane excitability and calcium handling.

Conclusion

We conclude that congenital absence of cardiac NBCe1-B leads to mechanical and electrical cardiac dysfunction in KOb/c mice that is likely driven by dysregulated cardiomyocyte Ca2+-handling.

Funding

  • NIDDK Support